<H1>Chapter DOI: 10.1208/aapsj070366<br/>Cited-By Count: 26</H1><table border="1" width="30%"><tr><td>Total References</td><td>72</td></tr><tr><td>Springer references</td><td>13</td></tr><tr><td>Non Springer references</td><td>59</td></tr><tr><td>BibStructured Count</td><td width="10%">71</td></tr><tr><td>BibUnstructured Count</td><td width="10%">1</td></tr><tr><td>DOI already available in SpringerLink</td><td>54</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>1</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>1</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>1</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Galmarini CM, Galmarini FC. Multidrug resistance in cancer therapy: role of the microenvironment.<Emphasis Type="Italic">Curr Opin Investig Drugs</Emphasis>. 2003;4:1416&#8211;1421.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR2</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Hryniuk</span> <span style='background:#DDDDDD'>WM</span></span></aug>. <span style='background:#CCCCFF'>The importance of dose intensity in the outcome of chemotherapy</span>. In: <span style='background:#CCFF99'><i>Important Adv Oncol</i></span>. <span style='background:#66FF66'>1988</span>:<span style='background:#D279FF'>121&#8211;141</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Masson E, Zamboni WC. PK optimisation of cancer chemotherapy: effect on outcomes.<Emphasis Type="Italic">Clin Pharmacokinet</Emphasis>. 1997;32:324&#8211;343.</td><td><a href=http://dx.doi.org/10.2165/00003088-199732040-00005>10.2165/00003088-199732040-00005</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Yuan F. Transvascular drug delivery in solid tumors.<Emphasis Type="Italic">Semin Radiat Oncol</Emphasis>. 1998;8:164&#8211;175.</td><td><a href=http://dx.doi.org/10.1016/S1053-4296(98)80042-8>10.1016/S1053-4296(98)80042-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Jain RK. Delivery of molecular and cellular medicine to solid tumors.<Emphasis Type="Italic">Adv Drug Deliv Rev.</Emphasis>, 2001;46:149&#8211;168.</td><td><a href=http://dx.doi.org/10.1016/S0169-409X(00)00131-9>10.1016/S0169-409X(00)00131-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Tong RT, Boucher Y, Kozin SV, Winkler F, Hicklin DJ, Jain RK. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors.<Emphasis Type="Italic">Cancer Res</Emphasis>. 2004;64:3731&#8211;3736.</td><td><a href=http://dx.doi.org/10.1158/0008-5472.CAN-04-0074>10.1158/0008-5472.CAN-04-0074</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>M&#252;ller M, Mader RM, Steiner B, et al. 5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients.<Emphasis Type="Italic">Cancer Res</Emphasis>. 1997;57:2598&#8211;2601.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Hunz M, Jetter A, Wilde S, et al. Plasma and tissue PKs of epirubicin in nine patients with primary breast cancer.<Emphasis Type="Italic">Eur J Clin Pharmacol</Emphasis>. 2001;57:A31.</td><td><a href=http://dx.doi.org/10.1007/s002280100268>10.1007/s002280100268</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Garimella TS, Ross DD, Eiseman JL, et al. Plasma PKs and tissue distribution of the breast cancer resistance protein (BCRP/ABCG2) inhibitor fumitremorgin C in SCID mice bearing T8 tumors.<Emphasis Type="Italic">Cancer Chemother Pharmacol</Emphasis>. 2005;55:101&#8211;109.</td><td><a href=http://dx.doi.org/10.1007/s00280-004-0866-2>10.1007/s00280-004-0866-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Meikle SR, Matthews JC, Brock CS, et al. PK assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility study.<Emphasis Type="Italic">Cancer Chemother Pharmacol</Emphasis>. 1998;42:183&#8211;193.</td><td><a href=http://dx.doi.org/10.1007/s002800050804>10.1007/s002800050804</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Fischman AJ, Alpert NM, Babich JW, Rubin RH. The role of positron emission tomography in PK analysis.<Emphasis Type="Italic">Drug Metab Rev</Emphasis>. 1997;29:923&#8211;956.</td><td><a href=http://dx.doi.org/10.3109/03602539709002238>10.3109/03602539709002238</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Jynge P, Skjetne T, Gribbestad I, et al., In vivo tissue PKs by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans.<Emphasis Type="Italic">Clin Pharmacol Ther</Emphasis>. 1990;48:481&#8211;489.</td><td><a href=http://dx.doi.org/10.1038/clpt.1990.183>10.1038/clpt.1990.183</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Artemov D, Solaiyappan M, Bhujwalla ZM. Magnetic resonance pharmacoangiography to detect and predict chemotherapy delivery to solid tumors.<Emphasis Type="Italic">Cancer Res</Emphasis>. 2001;61:3039&#8211;3044.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Benveniste H, Huttemeier PC. Microdialysis&#8212;theory and application.<Emphasis Type="Italic">Prog Neurobiol</Emphasis>. 1990;35:195&#8211;215.</td><td><a href=http://dx.doi.org/10.1016/0301-0082(90)90027-E>10.1016/0301-0082(90)90027-E</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Ungerstedt U. Microdialysis&#8212;principles and applications for studies in animals and man.<Emphasis Type="Italic">J Intern Med</Emphasis>. 1991;230:365&#8211;373.</td><td><a href=http://dx.doi.org/10.1111/j.1365-2796.1991.tb00459.x>10.1111/j.1365-2796.1991.tb00459.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Benveniste H. Brain microdialysis.<Emphasis Type="Italic">J Neurochem.</Emphasis> 1989;52:1667&#8211;1679.</td><td><a href=http://dx.doi.org/10.1111/j.1471-4159.1989.tb07243.x>10.1111/j.1471-4159.1989.tb07243.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Elmquist WF, Sawchuk RJ. Application of microdialysis in PK studies.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1997;14:267&#8211;288.</td><td><a href=http://dx.doi.org/10.1023/A:1012081501464>10.1023/A:1012081501464</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Garrison KE, Pasas SA, Cooper JD, Davies MI. A review of membrane sampling from biological tissues with applications in PKs, metabolism and PDs.<Emphasis Type="Italic">Eur J Pharm Sci</Emphasis>. 2002;17:1&#8211;12.</td><td><a href=http://dx.doi.org/10.1016/S0928-0987(02)00149-5>10.1016/S0928-0987(02)00149-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Chu J, Gallo JM. Application of microdialysis to characterize drug disposition in tumors.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2000;45:243&#8211;253.</td><td><a href=http://dx.doi.org/10.1016/S0169-409X(00)00115-0>10.1016/S0169-409X(00)00115-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Mader RM, Schrolnberger C, Rizovski B, et al. Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer.<Emphasis Type="Italic">Br J Cancer</Emphasis>. 2003;88:782&#8211;787.</td><td><a href=http://dx.doi.org/10.1038/sj.bjc.6600809>10.1038/sj.bjc.6600809</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Brunner M, Muller M. Microdialysis: an in vivo approach for measuring drug delivery in oncology.<Emphasis Type="Italic">Eur J Clin Pharmacol</Emphasis>. 2002;58:227&#8211;234.</td><td><a href=http://dx.doi.org/10.1007/s00228-002-0475-0>10.1007/s00228-002-0475-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Johnson RD, Justice JB. Model studies for brain dialysis.<Emphasis Type="Italic">Brain Res Bull</Emphasis>. 1983;10:567&#8211;571.</td><td><a href=http://dx.doi.org/10.1016/0361-9230(83)90156-9>10.1016/0361-9230(83)90156-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibChapter</td><td>Ungerstedt U. Measurement of transmitter release by intracerebral dialysis. In: Marsden CA, ed.<Emphasis Type="Italic">Measurement of Neurotransmitter Release In Vivo</Emphasis>. Chichester, UK: John Wiley &amp; Sons; 1984:81&#8211;105.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR24</td><td>BibArticle</td><td>St&#229;hle L. On mathematical models of microdialysis: geometry, steady-state models, recovery and probe radius.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2000;45:149&#8211;167.</td><td><a href=http://dx.doi.org/10.1016/S0169-409X(00)00108-3>10.1016/S0169-409X(00)00108-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>L&#246;nnroth P, Jansson P, Smith U. A microdialysis method allowing characterization of intercellular water space in humans.<Emphasis Type="Italic">Am J Physiol</Emphasis>. 1987;253:E228-E231.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR26</td><td>BibArticle</td><td>St&#229;hle L. Drug distribution studies with microdialysis. I. Tissue dependent difference in recovery between caffeine and theophylline.<Emphasis Type="Italic">Life Sci</Emphasis>. 1991;49:1835&#8211;1842.</td><td><a href=http://dx.doi.org/10.1016/0024-3205(91)90486-U>10.1016/0024-3205(91)90486-U</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Larsson CI. The use of an &#8220;internal standard&#8221; for control of the recovery in microdialysis.<Emphasis Type="Italic">Life Sci</Emphasis>. 1991;49:PL73-PL78.</td><td><a href=http://dx.doi.org/10.1016/0024-3205(91)90082-M>10.1016/0024-3205(91)90082-M</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Menacherry S Jr, Hubert W Jr. Justice JB Jr. In vivo calibration of microdialysis probes for exogenous compounds.<Emphasis Type="Italic">Anal Chem</Emphasis> 1992;64:577&#8211;583.</td><td><a href=http://dx.doi.org/10.1021/ac00030a003>10.1021/ac00030a003</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Yokel RA, Allen DD, Burgio DE, McNamara PJ. Antipyrine as a dialyzable reference to correct differences in efficiency among and within sampling devices during in vivo microdialysis.<Emphasis Type="Italic">J Pharmacol Toxicol Methods</Emphasis>. 1992;27:135&#8211;142.</td><td><a href=http://dx.doi.org/10.1016/1056-8719(92)90034-X>10.1016/1056-8719(92)90034-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Van Belle K, Dzeka T, Sarre S, Ebinger G, Michotte Y. In vitro and in vivo microdialysis calibration for the measurement of carbamazepine and its metabolites in rat brain tissue using the internal reference technique.<Emphasis Type="Italic">J Neurosci Methods</Emphasis> 1993;49:167&#8211;173.</td><td><a href=http://dx.doi.org/10.1016/0165-0270(93)90120-G>10.1016/0165-0270(93)90120-G</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Wang Y, Wong SL, Sawchuk RJ. Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus.<Emphasis Type="Italic">Pharm Res.</Emphasis> 1993;10:1411&#8211;1419.</td><td><a href=http://dx.doi.org/10.1023/A:1018906821725>10.1023/A:1018906821725</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Le Quellec A, Dupin S, Genissel P, Saivin S, Marchand B, Houin G. Microdialysis probes calibration: gradient and tissue dependent changes in no net flux and reverse dialysis methods.<Emphasis Type="Italic">J Pharmacol Toxicol Methods</Emphasis>. 1995;33:11&#8211;16.</td><td><a href=http://dx.doi.org/10.1016/1056-8719(94)00049-A>10.1016/1056-8719(94)00049-A</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Clement R, Malinovsky JM, Dollo G, Le Corre P, Chevanne F, Le Verge R. In vitro and in vivo microdialysis calibration using retrodialysis for the study of the cerebrospinal distribution of bupivacaine.<Emphasis Type="Italic">J Pharm Biomed Anal</Emphasis> 1998;17:665&#8211;670.</td><td><a href=http://dx.doi.org/10.1016/S0731-7085(97)00274-4>10.1016/S0731-7085(97)00274-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>St&#229;hle L. Drug distribution studies with microdialysis. I. Tissue dependent difference in recovery between caffeine and theophylline.<Emphasis Type="Italic">Life Sci.</Emphasis> 1991;49:1835&#8211;1842.</td><td><a href=http://dx.doi.org/10.1016/0024-3205(91)90486-U>10.1016/0024-3205(91)90486-U</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Stenken JA. Methods and issues in microdialysis calibration.<Emphasis Type="Italic">Anal Chim Acta</Emphasis>. 1999;379:337&#8211;358.</td><td><a href=http://dx.doi.org/10.1016/S0003-2670(98)00598-4>10.1016/S0003-2670(98)00598-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Chaurasia CS. In vivo microdialysis sampling: theory and applications.<Emphasis Type="Italic">Biomed Chromatogr.</Emphasis> 1999;13:317&#8211;332.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1099-0801(199908)13:5&lt;317::AID-BMC891&gt;3.0.CO;2-I>10.1002/(SICI)1099-0801(199908)13:5&lt;317::AID-BMC891&gt;3.0.CO;2-I</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Jacobson I, Sandberg M, Hamberger A. Mass transfer in brain dialysis devices&#8212;a new method for the estimation of extracellular amino acids concentration.<Emphasis Type="Italic">J Neurosci Methods</Emphasis>. 1985;15:263&#8211;268.</td><td><a href=http://dx.doi.org/10.1016/0165-0270(85)90107-4>10.1016/0165-0270(85)90107-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Trickler WJ, Miller DW. Use of osmotic agents in microdialysis studies to improve the recovery of macromolecules.<Emphasis Type="Italic">J Pharm Sci.</Emphasis> 2003;92:1419&#8211;1427.</td><td><a href=http://dx.doi.org/10.1002/jps.10410>10.1002/jps.10410</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Dabrosin C, Margetts PJ, Gauldie J. Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer.<Emphasis Type="Italic">Int J Cancer</Emphasis>. 2003;107:535&#8211;540.</td><td><a href=http://dx.doi.org/10.1002/ijc.11398>10.1002/ijc.11398</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Sjogren F, Svensson C, Anderson C. Technical prerequisites for in vivo microdialysis determination of interleukin-6 in human dermis.<Emphasis Type="Italic">Br J Dermatol.</Emphasis> 2002;146:375&#8211;382.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2133.2002.04621.x>10.1046/j.1365-2133.2002.04621.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Rosdahl H, Ungerstedt U, Henriksson J. Microdialysis in human skeletal muscle and adipose tissue at low flow rates is possible if dextran-70 is added to prevent loss of perfusion fluid.<Emphasis Type="Italic">Acta Physiol Scand</Emphasis>. 1997;159:261&#8211;262.</td><td><a href=http://dx.doi.org/10.1046/j.1365-201X.1997.123358000.x>10.1046/j.1365-201X.1997.123358000.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Ault JM, Riley CM, Meltzer NM, Lunte CE. Dermal microdialysis sampling in vivo.<Emphasis Type="Italic">Pharm Res.</Emphasis> 1994;11:1631&#8211;1639.</td><td><a href=http://dx.doi.org/10.1023/A:1018922123774>10.1023/A:1018922123774</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Davies MI, Lunte CE. Microdialysis sampling for hepatic metabolism studies: impact of microdialysis probe design and implantation technique on liver tissue.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 1995;23:1072&#8211;1079.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Palsmeier RK, Lunte CE. Microdialysis sampling of tumors for study of the metabolism of antineoplastic agents.<Emphasis Type="Italic">Cancer Bull</Emphasis>. 1994;46:58&#8211;66.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Westergren I, Nystrom B, Hamberger A, Johansson BB. Intracerebral dialysis and the blood-brain barrier.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1995;64:229&#8211;234.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.1995.64010229.x>10.1046/j.1471-4159.1995.64010229.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Morgan ME, Singhal D, Anderson BD. Quantitative assessment of blood-brain barrier damage during microdialysis.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1996;277:1167&#8211;1176.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Groothuis DR, Ward S, Schlageter KE, et al. Changes in blood-brain barrier permeability associated with insertion of brain cannulas and microdialysis probes.<Emphasis Type="Italic">Brain Res.</Emphasis> 1998;803:218&#8211;230.</td><td><a href=http://dx.doi.org/10.1016/S0006-8993(98)00572-1>10.1016/S0006-8993(98)00572-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR48</td><td>BibArticle</td><td>Joukhadar C, Klein N, Mader RM, et al. Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma.<Emphasis Type="Italic">Cancer</Emphasis>. 2001;92:2190&#8211;2196.</td><td><a href=http://dx.doi.org/10.1002/1097-0142(20011015)92:8&lt;2190::AID-CNCR1562&gt;3.0.CO;2-2>10.1002/1097-0142(20011015)92:8&lt;2190::AID-CNCR1562&gt;3.0.CO;2-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Johansen MJ, Thapar N, Newman RA, Madden T. Use of microdialysis to study platinum anticancer agent PKs in preclinical models.<Emphasis Type="Italic">J Exp Ther Oncol</Emphasis>. 2002;2:163&#8211;173.</td><td><a href=http://dx.doi.org/10.1046/j.1359-4117.2002.01019.x>10.1046/j.1359-4117.2002.01019.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR50</td><td>BibArticle</td><td>Zamboni WC, Gervais AC, Egorin MJ, et al. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.<Emphasis Type="Italic">Clin Cancer Res.</Emphasis> 2002;8:2992&#8211;2999.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR51</td><td>BibArticle</td><td>Dukic SF, Kaltenbach ML, Heurtaux T, Hoizey G, Lallemand A, Vistelle R. Influence of C6 and CNS1 brain tumors on methotrexate PKs in plasma and brain tissue.<Emphasis Type="Italic">J Neurooncol.</Emphasis> 2004;67:131&#8211;138.</td><td><a href=http://dx.doi.org/10.1023/B:NEON.0000021820.12444.4c>10.1023/B:NEON.0000021820.12444.4c</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR52</td><td>BibArticle</td><td>Leggas M, Zhuang Y, Welden J, Self Z, Waters CM, Stewart CF. Microbore HPLC method with online microdialysis for measurement of topotecan lactone and carboxylate in murine CitCSF.<Emphasis Type="Italic">J Pharm Sci.</Emphasis> 2004;93:2284&#8211;2295.</td><td><a href=http://dx.doi.org/10.1002/jps.20134>10.1002/jps.20134</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR53</td><td>BibArticle</td><td>Tokunaga Y, Nakashima M, Sasaki H, et al. Local distribution into brain tumor and PKs of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.<Emphasis Type="Italic">Biol Pharm Bull</Emphasis>. 2000;23:1491&#8211;1496.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR54</td><td>BibArticle</td><td>Zamboni WC, Gervais AC, Egorin MJ, et al. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumors model of melanoma.<Emphasis Type="Italic">Cancer Chemother Pharmacol</Emphasis>. 2004;53:329&#8211;336.</td><td><a href=http://dx.doi.org/10.1007/s00280-003-0719-4>10.1007/s00280-003-0719-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR55</td><td>BibArticle</td><td>Ma J, Pulfer S, Li S, Chu J, Reed K, Gallo JM. PD-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.<Emphasis Type="Italic">Cancer Res</Emphasis>. 2001;61:5491&#8211;5498.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR56</td><td>BibArticle</td><td>Ma J, Li S, Reed K, Guo P, Gallo JM. PD-mediated effects of the angiogenesis inhibitor SU5416 on the tumor disposition of temozolomide in subcutaneous and intracerebral glioma xenograft models.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;305:833&#8211;839.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.048587>10.1124/jpet.102.048587</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR57</td><td>BibArticle</td><td>Harrington KJ, Lewanski CR, Northcote AD, et al. Phase I&#8211;II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer.<Emphasis Type="Italic">Ann Oncol.</Emphasis> 2001;12:493&#8211;496.</td><td><a href=http://dx.doi.org/10.1023/A:1011199028318>10.1023/A:1011199028318</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR58</td><td>BibArticle</td><td>Devineni D, Klein-Szanto A, Gallo JM. In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats.<Emphasis Type="Italic">Cancer Chemother Pharmacol</Emphasis>. 1996;38:499&#8211;507.</td><td><a href=http://dx.doi.org/10.1007/s002800050518>10.1007/s002800050518</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR59</td><td>BibArticle</td><td>Devineni D, Klein-Szanto A, Gallo JM. Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.<Emphasis Type="Italic">Cancer Res.</Emphasis> 1996;56:1983&#8211;1987.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR60</td><td>BibArticle</td><td>Teicher BA, Dupuis NP, Robinson MF, Emi Y, Goff DA. Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma.<Emphasis Type="Italic">Oncol Res.</Emphasis> 1995;7:237&#8211;243.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR61</td><td>BibArticle</td><td>Tegeder I, Brautigam L, Seegel M, et al. Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer.<Emphasis Type="Italic">Clin Pharmacol Ther.</Emphasis> 2003;73:417&#8211;426.</td><td><a href=http://dx.doi.org/10.1016/S0009-9236(03)00008-0>10.1016/S0009-9236(03)00008-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR62</td><td>BibArticle</td><td>Joukhadar C, Klein N, Mader RM, et al. Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma.<Emphasis Type="Italic">Cancer</Emphasis>. 2001;92:2190&#8211;2196.</td><td><a href=http://dx.doi.org/10.1002/1097-0142(20011015)92:8&lt;2190::AID-CNCR1562&gt;3.0.CO;2-2>10.1002/1097-0142(20011015)92:8&lt;2190::AID-CNCR1562&gt;3.0.CO;2-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR63</td><td>BibArticle</td><td>Ekstrom PO, Andersen A, Saeter G, Giercksky KE, Slordal L. Continuous intratumoral microdialysis during high-dose methotrexate therapy in a patient with malignant fibrous histiocytoma of the femur: a case report.<Emphasis Type="Italic">Cancer Chemother Pharmacol</Emphasis>. 1997;39:267&#8211;272.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1007/s002800050571>10.1007/s002800050571</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, ArticleTitle, FirstPage, VolumeID</td><td>CrossRef</td></tr><tr><td>CR64</td><td>BibArticle</td><td>M&#252;ller M, Brunner M, Schmid R, et al. Intestitials methotrexate kinetics in primary breast cancer lesions.<Emphasis Type="Italic">Cancer Res</Emphasis>. 1998;58:2982&#8211;2985.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR65</td><td>BibArticle</td><td>Sch&#252;ller J, Cassidy J, Dumont E, et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.<Emphasis Type="Italic">Cancer Chemother Pharmacol</Emphasis>. 2000;45:291&#8211;297.</td><td><a href=http://dx.doi.org/10.1007/s002800050043>10.1007/s002800050043</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR66</td><td>BibArticle</td><td>Abe R, Akiyoshi T, Baba T. Inactivation of cisdiamminedichloroplatinum (II) in blood by sodium thiosulfate.<Emphasis Type="Italic">Oncology</Emphasis>, 1990;47:65&#8211;69.</td><td><a href=http://dx.doi.org/10.1159/000226787>10.1159/000226787</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR67</td><td>BibArticle</td><td>Zamboni WC, Houghton PJ, Hulstein JL, et al. Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines.<Emphasis Type="Italic">Cancer Chemother Pharmacol</Emphasis>. 1999;43:269&#8211;276.</td><td><a href=http://dx.doi.org/10.1007/s002800050894>10.1007/s002800050894</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR68</td><td>BibArticle</td><td>Gallo JM, Vicini P, Orlansky A, et al. PK model-predicted anticancer drug concentration in human tumors.<Emphasis Type="Italic">Clin Cancer Res</Emphasis>. 2004;10:8048&#8211;8058.</td><td><a href=http://dx.doi.org/10.1158/1078-0432.CCR-04-0822>10.1158/1078-0432.CCR-04-0822</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR69</td><td>BibArticle</td><td>Castejon AM, Paez X, Hernandez L, Cubeddu LX. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisertron and ondansetron.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>.1999;291:960&#8211;966.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR70</td><td>BibArticle</td><td>Paez X, Hernandez L. Plasma serotonin monitoring by blood microdialysis coupled to high-performance liquid chromatography with electrochemical detection in humans.<Emphasis Type="Italic">J Chromatogr B Biomed Sci Appl.</Emphasis> 1998;720:33&#8211;38.</td><td><a href=http://dx.doi.org/10.1016/S0378-4347(98)00417-4>10.1016/S0378-4347(98)00417-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR71</td><td>BibArticle</td><td>Garvin S, Dabrosin C. Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.<Emphasis Type="Italic">Cancer Res</Emphasis>. 2003;63:8742&#8211;8748.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR72</td><td>BibArticle</td><td>Dabrosin C. Variability of vascular endothelial growth factor in normal human breast tissue in vivo during the menstrual cycle.<Emphasis Type="Italic">J Clin Endocrinol Metab</Emphasis>. 2003;88:2695&#8211;2698.</td><td><a href=http://dx.doi.org/10.1210/jc.2002-021584>10.1210/jc.2002-021584</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>